La COB et le CMF réglementent la prestation de services financiers en ligne = COB and CMF regulate the prestation of online financial servicesLIPSKIER, M.Expertises des systèmes d'information. 2000, Num 233, pp 432-433, issn 0221-2102Article

Steel against seismic risk: the Italian case = Acier contre les risques sismiques: le cas de l'ItalieDE MARTINO, G.Acier (Ed. française). 1984, Vol 49, Num 4, pp 166-172, issn 0375-832XArticle

ADRIAMYCIN PLUS VINCRISTINE COMPARED TO AND COMBINED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL FOR ADVANCED BREAST CANCER = COMPARAISON ET ASSOCIATION DE L'ADRIAMYCINE PLUS VINCRISTINE AU CYCLOPHOSPHAMIDE, METHOTREXATE ET FLUORO-5 URACIL POUR LE CANCER DU SEIN AVANCEDE LENA M; BRAMBILLA C; MORABITO A et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 35; NO 4; PP. 1108-1115; BIBL. 21 REF.Article

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients : Safety data from the multicentre phase 3 randomised ELDA trialNUZZO, Francesco; MORABITO, Alessandro; D'AIUTO, Giuseppe et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 2, pp 171-180, issn 1040-8428, 10 p.Article

METASTATIC ADENOCARCINOMAS OF UNKOWN PRIMARY SITE: A RANDOMIZED STUDY OF TWO COMBINATION-CHEMOTHERAPY REGIMENSWOODS RL; FOX RM; TATTERSALL MHN et al.1980; NEW ENGL. J. MED.; USA; DA. 1980; VOL. 303; NO 2; PP. 87-89; BIBL. 11 REF.Article

Occurrence and behavior of four of the most used sunscreen UV filters in a wastewater reclamation plantWEIHONG LI; YONGMIN MA; CHANGSHENG GUO et al.Water research (Oxford). 2007, Vol 41, Num 15, pp 3506-3512, issn 0043-1354, 7 p.Article

Activite antifongique et screening phytochimique de thos (extrait aqueux de Thonningia sanguinea) = Antifungal activity and phytochemical screening of aqueous extract of Thonningia sanguineaKOUAKOU, A. V; N'GUESSAN, J. D; KRA, A. K. M et al.Journal de la Société ouest-africaine de chimie. 2006, Num 22, pp 21-25, issn 0796-6687, 5 p.Article

ESTROGEN-RECEPTOR STATUS AND RESPONSE TO CHEMOTHERAPY IN EARLY AND ADVANCED BREAST CANCERBONADONNA G; VALAGUSSA P; TANCINI G et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 1; PP. 37-41; BIBL. 24 REF.Article

CHIMIOTHERAPIE ANI-CANCEREUSE: CONDUITE PRATIQUE ET COORDINATION MEDICALEHOERNI B; DURAND M; CHAUVERGNE J et al.1978; BULL. CANCER; FRA; DA. 1978; VOL. 65; PP. 395-400; ABS. ENG; BIBL. 7 REF.Article

Pothomorphe umbellata: Antifungal activity against strains of Trichophyton rubrumRODRIGUES, E. R; NOGUEIRA, N. G. P; ZOCOLO, G. J et al.Journal de mycologie médicale. 2012, Vol 22, Num 3, pp 265-269, issn 1156-5233, 5 p.Article

Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative studySPARK, Y; OKAMURA, K; KOMICHI, H et al.British journal of cancer. 2009, Vol 101, Num 4, pp 598-604, issn 0007-0920, 7 p.Article

CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN ADVANCED GASTROINTESTINAL CANCERSCANNI A; TOMIROTTI M; MARGULIS A et al.1979; TUMORI; ITA; DA. 1979; VOL. 65; NO 1; PP. 111-117; ABS. ITA; BIBL. 10 REF.Article

QUE FAIRE DEVANT UNE TUMEUR DU SEIN OPEREE.GISSELBRECHT C; GORINS A; MARTY M et al.1978; ENTRET. DE BICHAT, THERAPEUT.; FRA; DA. 1978; PP. 17-19; BIBL. 6 REF.Conference Paper

Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)OHASHI, Yasuo; WATANABE, Toru; SANO, Muneaki et al.Breast cancer research and treatment. 2010, Vol 119, Num 3, pp 633-641, issn 0167-6806, 9 p.Article

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)PESTALOZZI, B. C; ZAHRIEH, D; SIMONCINI, E et al.Annals of oncology. 2006, Vol 17, Num 6, pp 935-944, issn 0923-7534, 10 p.Article

1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery : A randomized controlled trialTOMINAGA, Takeshi; KIMURA, Morihiko; AOYAMA, Hideaki et al.Oncology reports. 2004, Vol 12, Num 4, pp 797-803, issn 1021-335X, 7 p.Article

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancerCAMERON, D. A; MASSIE, C; KERR, G et al.British journal of cancer. 2003, Vol 89, Num 10, pp 1837-1842, issn 0007-0920, 6 p.Article

Survival analyses from the ZEBRA study: goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancerKAUFMANN, M; JONAT, W; BLAMEY, R et al.European journal of cancer (1990). 2003, Vol 39, Num 12, pp 1711-1717, issn 0959-8049, 7 p.Article

CHIMIOTHERAPIE DES CANCERS DU SEIN EVOLUES. ANALYSE PRELIMINAIRE D'UN ESSAI THERAPEUTIQUE CONTROLE PORTANT SUR 100 MALADESMARTRON JEAN LOUIS.1979; ; FRA; BORDEAUX: AMICALE CORP. ETUD. MED.; DA. 1979; 148; 52 P.: ILL.; 23 CM; BIBL. 16 REF.; TH.: MED./BORDEAUX 2/1979Thesis

The CMF-regimen. Toxicity patterns following stepwise combinations of cyclophosphamide, methotrexate and fluorouracilDE BRUIJN, E. A; DRIESSEN, O. M. J; HERMANS, J et al.International journal of cancer. 1991, Vol 48, Num 1, pp 67-72, issn 0020-7136, 6 p.Article

A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodesCancer research (Baltimore). 1985, Vol 45, Num 9, pp 4454-4459, issn 0008-5472Article

Chemotherapy drug dose alteration due to radiation therapy in an adjuvant situation in breast cancerBANERJEE, T. K; HOEHN, J. L; GREENLAW, R. H et al.American journal of clinical oncology. 1984, Vol 7, Num 5, pp 437-442, issn 0277-3732Article

COMPARISON OF INDUCTION CHEMOTHERAPIES FOR METASTATIC BREAST CANCER. AN EASTERN COOPERATIVE ONCOLOGY GROUP TRIALTORMEY DC; GELMAN R; BAND PR et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 7; PP. 1235-1244; BIBL. 32 REF.Article

Adjuvant chemotherapy with and without radiotherapy in stage II breast cancerBRUFMAN, G; SULKES, A; BIRAN, S et al.Biomedicine & pharmacotherapy. 1988, Vol 42, Num 5, pp 351-355, issn 0753-3322Article

Adjuvant chemo-immunotherapy in stage II carcinoma of the breastGIULIANO, A. E; SPARKS, F. C; PATTERSON, K et al.Journal of surgical oncology. 1986, Vol 31, Num 4, pp 255-259, issn 0022-4790Article